How many email patterns does NeuClone use?

NeuClone uses 1 known email pattern.

What domain does NeuClone use for work emails?

NeuClone uses neuclone.com for work email addresses.

Most Common Email Formats at NeuClone

The most accurate and popular NeuClone's email format is F.Last@neuclone.com (ex. J.Doe@neuclone.com). NeuClone also uses as email structures. NeuClone uses up to 1 different email patterns.

NeuClone Email Formats	Example	Percentage
F.Last@neuclone.com	J.Doe@neuclone.com	100%

Frequently Asked Questions

What does NeuClone do?

operates in the Pharmaceutical Manufacturing industry, along with similar companies like ImmaticsVAXIMM AGPionyr Immunotherapeutics. You can visit neuclone.com. Explore NeuClone's company overview page for more information.

What is NeuClone's email address format?

NeuClone's email format typically follows the pattern of F.Last@neuclone.com; this email format is used 100% of the time. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does NeuClone have currently?

NeuClone has approximately 9 employees as of July 2026. Key team members to contact include Cfo / Legal Counsel / Director: J. M.Chief Development Officer: P. A.Head Of Global Business Development And Alliances: J. O.. For more team information and contact data, explore NeuClone's employee directory with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

NeuClone Email Format

Q: What is NeuClone's email address format?

NeuClone's email format typically follows the pattern of ${fi}.${ln}.

Pharmaceutical ManufacturingNew South Wales, Australia2-10 Employees

NeuClone is a small, clinical-stage biopharmaceutical company focused on developing and commercialising biosimilar medicines. Based in Sydney, Australia, it operates within the pharmaceutical manufacturing sector and is led by a team of industry veterans. The company aims to build a deep pipeline of biosimilars that can be produced at scale and offered at prices designed to meet demand in both new and established markets worldwide, with an approach that emphasizes confirming biosimilarity early and throughout development.

Its target market encompasses global healthcare systems and patients seeking affordable biosimilar options, with a focus on achieving global registration and broad access. In 2019 the company advanced its ustekinumab biosimilar NeuLara into a Phase I trial. Earlier, NeuClone partnered with Serum Institute to develop ten biosimilars for global registration.

Verify NeuClone email addresses

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Most Common Email Formats at NeuClone

Frequently Asked Questions

What does NeuClone do?

What is NeuClone's email address format?

How many employees does NeuClone have currently?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

NeuClone Email Format

Verify NeuClone email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Everything for prospecting,
in one platform.